---
title: "Kwick Forensic Solutions Ltd (1286123) — Share Price, Financials & Analysis"
symbol: "1286123"
company: "Kwick Forensic Solutions Ltd"
canonical: "https://tapetide.com/stocks/1286123"
bse_code: "544895"
sector: "Industrials"
industry: "Industrial Manufacturing"
generated_at: "2026-09-13T19:07:24.107Z"
---

# Kwick Forensic Solutions Ltd (1286123)

Canonical page: https://tapetide.com/stocks/1286123

## Company

- **BSE Code:** 544895
- **Sector:** Industrials
- **Industry:** Industrial Manufacturing
- **Macro Sector:** Industrials
- **Face Value:** ₹10
- **F&O Eligible:** No

## About

Incorporated in March 2005, Kwick Forensic Solutions Limited (formerly Kwick Soft Solutions Private Limited) is engaged in providing forensic science, evidence management, cyber and digital forensics, DNA forensics, and law-enforcement solutions across India.[1]

## Latest Price

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 76.1% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 41.2%
- Debtor days have improved from 111 to 79.0 days.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | 58% | 96% | 76% |
| revenue growth | 63% | 73% | 56% |

## Financial Statements

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Sales | 12 | 4 | 20 | 30 | 65 | 106 |
| Expenses | 10 | 4 | 17 | 25 | 53 | 87 |
| Operating Profit | 2 | 0 | 3 | 5 | 12 | 19 |
| OPM % | 15 | 9 | 16 | 18 | 19 | 18 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 0 | 1 | 1 | 1 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 1 | 0 | 2 | 4 | 11 | 18 |
| Tax % | 30 | 7 | 25 | 25 | 24 | 26 |
| Net Profit | 1 | 0 | 2 | 3 | 9 | 14 |
| EPS in Rs | 24.24 | 4.24 | 52.73 | 14.66 | 40.58 | 8.01 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.33 | 0.33 | 0.33 | 2 | 2 | 17 |
| Reserves | 2 | 2 | 4 | 8 | 26 | 25 |
| Borrowings | 2 | 1 | 6 | 3 | 3 | 0 |
| Other Liabilities | 2 | 2 | 3 | 6 | 16 | 19 |
| Total Liabilities | 6 | 6 | 13 | 19 | 47 | 61 |
| Fixed Assets | 0 | 0 | 1 | 1 | 1 | 3 |
| CWIP | 0 | 0 | 0 | 0 | 1 | 1 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 6 | 5 | 12 | 18 | 45 | 56 |
| Total Assets | 6 | 6 | 13 | 19 | 47 | 61 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 4 | -1 | 0 | -3 | 5 | 8 |
| Cash from Investing Activity | 0 | 0 | -1 | 0 | -1 | -3 |
| Cash from Financing Activity | -2 | 0 | 4 | -1 | 8 | -4 |
| Net Cash Flow | 2 | -1 | 4 | -4 | 12 | 1 |
| Free Cash Flow | 4 | -1 | -1 | -3 | 4 | 5 |
| CFO/OP | 217 | -356 | 14 | -37 | 46 | 55 |

### Ratios

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 45 | 34 | 32 | 144 | 111 | 79 |
| Inventory Days | 54 | 838 | 93 | 63 | 62 | 49 |
| Days Payable | 16 | 158 | 51 | 63 | 85 | 41 |
| Cash Conversion Cycle | 83 | 714 | 74 | 145 | 88 | 87 |
| Working Capital Days | 22 | 218 | -38 | 97 | 73 | 78 |
| ROCE % | — | 7 | 47 | 44 | 54 | 51 |

## Shareholding Pattern

### annual

| Category | Sep 2026 |
| --- | --- |
| Promoters | 64.65% |
| FIIs | 1.49% |
| DIIs | 10.85% |
| Public | 23.01% |
| No. of Shareholders | 896 |

### Quarterly

| Category | Sep 2026 |
| --- | --- |
| Promoters | 64.65% |
| FIIs | 1.49% |
| DIIs | 10.85% |
| Public | 23.01% |
| No. of Shareholders | 896 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Neutral
- **Buy / Neutral / Sell:** 0 / 19 / 0

### Moving Averages — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | — | Neutral |
| EMA (10) | — | Neutral |
| SMA (20) | — | Neutral |
| EMA (20) | — | Neutral |
| SMA (50) | — | Neutral |
| EMA (50) | — | Neutral |
| SMA (100) | — | Neutral |
| EMA (100) | — | Neutral |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | — | Neutral |
| MACD (12,26,9) | — | Neutral |
| Stochastic (14,3,3) | — | Neutral |
| ADX (14) | — | Neutral |
| Williams %R (14) | — | Neutral |
| ATR (14) | — | Neutral |
| ROC (12) | — | Neutral |
| Stoch RSI (14) | — | Neutral |
| UO (7,14,28) | — | Neutral |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:07:24.107Z.